Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in brain activity with tominersen in early-manifest Huntington's disease.

Brain communications·2022
Same author

Inflammation triggers production of dimethylsphingosine from oligodendrocytes.

Neuroscience·2014
Same author

Flexible metal-organic frameworks.

Chemical Society reviews·2014
Same author

Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome.

Neuroscience·2010
Same author

Hybrid assembly of CPMV viruses and surface characteristics of different mutants.

Current topics in microbiology and immunology·2009
Same author

Recent insights into the biology and biomedical applications of Flock House virus.

Cellular and molecular life sciences : CMLS·2008
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Biomedical nanotechnology using virus-based nanoparticles.

G Destito1, A Schneemann, M Manchester

  • 1Kirin Pharma USA, Inc., La Jolla, CA 92037, USA.

Current Topics in Microbiology and Immunology
|February 10, 2009
PubMed
Summary
This summary is machine-generated.

Virus nanoparticles offer a promising approach to precisely deliver therapeutics and vaccines, enhancing efficacy and reducing side effects. Cowpea mosaic virus (CPMV) and flock house virus (FHV) show potential for targeted delivery and structure-based vaccines.

More Related Videos

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

Area of Science:

  • Biomedical nanotechnology
  • Virology
  • Drug delivery systems

Background:

  • Targeting therapeutics to specific body locations is a major biomedical challenge.
  • Minimizing adverse effects and maximizing therapeutic benefits require precise delivery.
  • Virus-based nanotechnology leverages natural viral properties for targeted delivery.

Purpose of the Study:

  • To explore the potential of virus-based nanotechnology for targeted therapeutics and vaccines.
  • To highlight Cowpea mosaic virus (CPMV) and flock house virus (FHV) as promising platforms.
  • To advance structure-based vaccine design using viral nanoparticles.

Main Methods:

  • Utilizing Cowpea mosaic virus (CPMV) as a nanoparticle platform.
  • Employing flock house virus (FHV) for therapeutic and vaccine development.
  • Investigating the natural circulatory and targeting properties of viruses for in vivo applications.

Main Results:

  • Virus nanoparticles demonstrate potential for targeted delivery of therapeutics.
  • CPMV and FHV nanoparticle strategies show promise for in vivo targeting.
  • These viral platforms are suitable for developing targeted therapeutics and vaccines.

Conclusions:

  • Virus-based nanotechnology provides a viable strategy for targeted drug delivery.
  • CPMV and FHV nanoparticles offer versatile platforms for therapeutic and vaccine applications.
  • This approach enhances the potential for site-specific treatment and advanced vaccine design.